Cargando…

Combination immunohistochemistry for SMAD4 and Runt-related transcription factor 3 may identify a favorable prognostic subgroup of pancreatic ductal adenocarcinomas

PURPOSES: SMAD4/DPC4 mutations have been associated with aggressive behavior in pancreatic ductal adenocarcinomas (PDAC), and it has recently been suggested that RUNX3 expression combined with SMAD4 status may predict the metastatic potential of PDACs. We evaluated the prognostic utility of SMAD4/RU...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Yangkyu, Lee, Hyejung, Park, Hyunjin, Kim, Jin-Won, Hwang, Jin-Hyeok, Kim, Jaihwan, Yoon, Yoo-Seok, Han, Ho-Seong, Kim, Haeryoung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652736/ https://www.ncbi.nlm.nih.gov/pubmed/29100342 http://dx.doi.org/10.18632/oncotarget.20815

Ejemplares similares

Higher Tumor Cellularity in Resected Pancreatic Ductal Adenocarcinoma Is a Negative Prognostic Indicator
por: Cho, In Kuk, et al.
Publicado: (2020)

The Clinicopathological Significance of YAP/TAZ Expression in Hepatocellular Carcinoma with Relation to Hypoxia and Stemness
por: Park, Hyunjin, et al.
Publicado: (2021)

Multiple hepatocyte nuclear factor 1A (HNF1A)-inactivated hepatocellular adenomas arising in a background of congenital hepatic fibrosis
por: Lee, Yangkyu, et al.
Publicado: (2021)

The Clinicopathological and Prognostic Significance of the Gross Classification of Hepatocellular Carcinoma
por: Lee, Yangkyu, et al.
Publicado: (2018)

The Clinicopathological and Prognostic Significance of Nrf2 and Keap1 Expression in Hepatocellular Carcinoma
por: Lee, Kiryang, et al.
Publicado: (2020)

Prognostic significance of viable tumor size measurement in hepatocellular carcinomas after preoperative locoregional treatment
por: Hwang, Yoon Jung, et al.
Publicado: (2021)

Four-Tier Pathologic Tumor Regression Grading System Predicts the Clinical Outcome in Patients Who Undergo Surgical Resection for Locally Advanced Pancreatic Cancer after Neoadjuvant Chemotherapy
por: Ahn, Soomin, et al.
Publicado: (2022)

Maintenance of skeletal muscle mass during FOLFIRINOX is a favorable prognostic factor in pancreatic cancer patients
por: Shin, Dong Woo, et al.
Publicado: (2021)

Presence of pancreatic intraepithelial neoplasia-3 in a background of chronic pancreatitis in pancreatic cancer patients
por: Hwang, In Kyeom, et al.
Publicado: (2015)

Serum interleukin-6 is associated with pancreatic ductal adenocarcinoma progression pattern
por: Kim, Hyoung Woo, et al.
Publicado: (2017)

Initial Metastatic Site as a Prognostic Factor in Patients With Stage IV Pancreatic Ductal Adenocarcinoma
por: Kim, Hyoung Woo, et al.
Publicado: (2015)

Postoperative Carcinoembryonic Antigen as a Complementary Tumor Marker of Carbohydrate Antigen 19-9 in Pancreatic Ductal Adenocarcinoma
por: Kim, Jaihwan, et al.
Publicado: (2015)

Multi-Phase, Contrast-Enhanced Computed Tomography-Based Radiomic Prognostic Marker of Non-Metastatic Pancreatic Ductal Adenocarcinoma
por: Shin, Dong Woo, et al.
Publicado: (2022)

Human equilibrative nucleoside transporter 1 (hENT1) expression as a predictive biomarker for gemcitabine chemotherapy in biliary tract cancer
por: Kim, Jaihwan, et al.
Publicado: (2018)

High Expression of MicroRNA-196a Indicates Poor Prognosis in Resected Pancreatic Neuroendocrine Tumor
por: Lee, Yoon Suk, et al.
Publicado: (2015)

SALL4 Expression in Hepatocellular Carcinomas Is Associated with EpCAM-Positivity and a Poor Prognosis
por: Park, Hyunjin, et al.
Publicado: (2015)

Intrahepatic cholangiocarcinoma with predominant ductal plate malformation pattern
por: Choe, Ji-Young, et al.
Publicado: (2014)

Colonic manifestations of runt disease.
por: Singer, J. B., et al.
Publicado: (1966)

IMMUNOLOGIC INCOMPETENCE OF IMMUNOLOGICALLY RUNTED ANIMALS
por: Blaese, R. Michael, et al.
Publicado: (1964)

STUDIES ON THE IMMUNOTHERAPY OF RUNT DISEASE IN RATS
por: Silvers, Willys K., et al.
Publicado: (1969)

STUDIES ON THE RUNTING SYNDROME IN NEWBORN MICE
por: Siskind, Gregory W., et al.
Publicado: (1959)

Liquid-Based Cytology Features of Papillary Squamotransitional Cell Carcinoma of the Uterine Cervix
por: Lee, Yangkyu, et al.
Publicado: (2019)

Postoperative muscle mass restoration as a prognostic factor in patients with resected pancreatic cancer
por: Lee, Jongchan, et al.
Publicado: (2020)

Viral metagenomic analysis of chickens with runting-stunting syndrome in the Republic of Korea
por: Kim, Hye-Ryoung, et al.
Publicado: (2020)

Early versus delayed initiation of adjuvant treatment for pancreatic cancer
por: Kim, Hyoung Woo, et al.
Publicado: (2017)

Pharmacoethnicity of FOLFIRINOX versus gemcitabine plus nab-paclitaxel in metastatic pancreatic cancer: a systematic review and meta-analysis
por: Lee, Yoon Suk, et al.
Publicado: (2021)

Cdc6 disruption leads to centrosome abnormalities and chromosome instability in pancreatic cancer cells
por: Youn, Yuna, et al.
Publicado: (2020)

Involvement of the NF-κB signaling pathway in proliferation and invasion inhibited by Zwint-1 deficiency in Pancreatic Cancer Cells
por: Kim, Jae Hyeong, et al.
Publicado: (2020)

THE PRODUCTION OF RUNT DISEASE IN RATS THYMECTOMIZED AT BIRTH
por: Aisenberg, Alan C., et al.
Publicado: (1962)

Molecular subgrouping of medulloblastoma in pediatric population using the NanoString assay and comparison with immunohistochemistry methods
por: Kim, Joo Whan, et al.
Publicado: (2022)

The Role of CDX2 in Intestinal Metaplasia Evaluated Using Immunohistochemistry
por: Lee, Byoung Hwan, et al.
Publicado: (2012)

The Frequency of Korean Patients With Parkinson’s Disease Carrying GBA Mutations in a Subgroup With Age at Onset ≤ 55 Years Old
por: Hwangbo, Jin, et al.
Publicado: (2023)

Recent 5-Year Trend of Endoscopic Retrograde Cholangiography in Korea Using National Health Insurance Review and Assessment Service Open Data
por: Park, Jin Myung, et al.
Publicado: (2020)

Management of recurrent pancreatic cancer after surgical resection: a protocol for systematic review, evidence mapping and meta-analysis
por: Lee, Jong-chan, et al.
Publicado: (2018)

Neoadjuvant therapy versus upfront surgery in resectable pancreatic cancer according to intention-to-treat and per-protocol analysis: A systematic review and meta-analysis
por: Lee, Yoon Suk, et al.
Publicado: (2019)

Meta-Analysis of the Prognostic Value of Smad4 Immunohistochemistry in Various Cancers
por: Du, Yiping, et al.
Publicado: (2014)

Genetic, Clinicopathological, and Radiological Features of Intrahepatic Cholangiocarcinoma with Ductal Plate Malformation Pattern
por: Chung, Taek, et al.
Publicado: (2022)

AN ELECTRON MICROSCOPE STUDY OF LYMPHATIC TISSUE IN RUNT DISEASE
por: Weiss, Leon, et al.
Publicado: (1965)

Hairless is a cofactor for Runt-dependent transcriptional regulation
por: Walrad, Pegine B., et al.
Publicado: (2011)

High PD-L1 expression is associated with therapeutic response to pembrolizumab in patients with advanced biliary tract cancer
por: Ahn, Soomin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rk6i8rlup3ttmam1vb1851t4nr